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Background: A good in vitro model should approximate an in vivo-like behavior as closely as possible in order to
reflect most likely the in vivo situation. Regarding renal physiology of different species, humans are more closely
related to pigs than to rodents, therefore primary porcine kidney cells (PKC) and their subsequent cell strain could
be a valid alternative to primary human cells for renal in vitro toxicology. For this PKC must display inherent
characteristics (e.g. structural organization) and functions (e.g. transepithelial transport) as observed under in vivo
conditions within the respective part of the kidney.
Results: We carried out a comprehensive characterization of PKC and their subsequent cell strain, including
morphology and growth as well as transporter expression and functionality. The data presented here demonstrate
that PKC express various transporters including pMrp1 (abcc1), pMrp2 (abcc2), pOat1 (slc22a6) and pOat3 (slc22a8),
whereas pMdr1 (abcb1) and pOatp1a2 (slco1a2) mRNA could not be detected in either the PKCs or in the porcine
cortical tissue. Functionality of the transporters was demonstrated by determining the specific PAH transport
kinetics.
Conclusions: On the basis of the presented results it can be concluded that PKC and to some extent their
subsequent cell strain represent a valuable model for in vitro toxicology, which might be used as an alternative to
human primary cells.
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In vitro modelBackground
Recent discussions on the value of in vivo rodent bioassays
for risk assessment and risk extrapolation to humans dem-
onstrate the growing uneasiness of using rodents as surro-
gates for humans. Indeed humans are not 70 kg rodents
and thus it does not come as a surprise that rodents differ
physiologically and anatomically dramatically from humans
[1]. The ever growing number of well characterized
species-and sex-specific mechanisms of toxicity and car-
cinogenicity in rodents that have no comparison to and
thus no relevance for humans, e.g. the α2u-globulin ne-
phropathy/carcinogenesis [2], sodium-glucose linked trans-
porter (SGLT) inhibitor mediated renal carcinogenesis in* Correspondence: daniel.dietrich@uni-konstanz.de
Human and Environmental Toxicology, University of Konstanz, 78457
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distribution, and reproduction in any mediummice or rats [3], D-amino acid oxidase (DAAO) droplet
nephropathy in male and female rats [4] etc. are testimony
of the problems associated with using in vivo rodent bio-
assays to understand mechanisms of toxicity and the ex-
trapolation of potential risk to humans. Similarly, the use
of rodent primary cells in vitro, albeit providing for a more
defined and controlled testing system, is subject to the
same restrictions with regard to the extrapolation of find-
ings to the human situation. Consequently, there has been
a recent emphasis on employing human primary cells as
well as cell lines to allow delineation of the underlying
mechanisms of toxicity. While human cell lines are de-
rived from either cancer cells or have been transformed
using viral genes or DNA alkylating or oxidizing reactions
and thus bear little resemblance to ‘normal’ human cells,
employing human primary cells would be the most opti-
mal solution. However, human primary cells are difficultd Central Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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thus demand thinking of potential alternatives.
Indeed, the porcine kidney is anatomically and physiolo-
gically comparable with the human [5] and can be ob-
tained without real restrictions and at relatively low costs.
More importantly one of the real caveats in using cells
in vitro is the variable expression of transporters, the type
of transporters expressed, the level of expression, the
homology/amino acid identity and tertiary and quaternary
structures of the transporters as well as the transporter
type distribution within a given anatomical subunit e.g.
the proximal tubule epithelial cells at the basal membrane
of the luminal surface. Indeed, of the many human trans-
porters known, at least the fully sequenced porcine trans-
porters have a higher structural/amino acid identity to the
human homologues than those of either mice or rats
(Additional file 1: Figure S1, Additional file 2: Table S1).
The latter is also critical when kinetics as well as dynamics
of given compounds that need active or passive transport
across membranes are considered, as the higher the hom-
ology to the human transporter the higher the likelihood
that transport affinity and capacity are similar in the hu-
man and porcine homologues for the compound. This as-
sumption is supported by data available for OAT1 and to
some extent also for OAT3, whereas for other transporters
insufficient data is available for comparison (Additional
file 3: Table S2). However, in order to employ primary
porcine kidney cells (PKC) and their subsequent cell strain
for compound assessment it is crucial to demonstrate the
types and levels of transporters expressed, their function-
ality (transporting capability) as well as their consistent
expression over several cell culture passages. In order to
address the latter points of characterization, primary PKC
were generated from kidneys obtained from German hy-
brid pigs and cultured over several days and passages. The
latter resulted in a PKC cell strain with a finite lifespan
according to the traditional definition [6,7]. Moreover, as
transporters are expressed at the basolateral or luminal
side of renal epithelial cells only, compounds for testing
transport functionality were chosen that need two differ-
ently localized transporters for cellular uptake and excre-
tion, respectively. Finally in order to determine whether
the expression of given transporters are hormone or sub-
strate dependent, specific treatments were employed to
detect differences in expression transporter levels.
In addition, two continuous cell lines of rat (NRK-52E)
and porcine (LLC-PK1) origin that are often used in
in vitro renal toxicology were run alongside for comparison.
Methods
Materials
Unless stated otherwise, materials were purchased from
the following commercial suppliers: PAA Laboratories
GmbH, Cölbe, Germany (cell culture chemicals), Sarstedt,Nümbrecht, Germany (cell culture plastics), BD Biosci-
ences, Heidelberg, Germany (Primaria™ cell culture plastic
ware, filter inserts), Fermentas, St. Leon-Rot, Germany (mo-
lecular biology reagents), MWG Biotech AG, Ebersberg,
Germany (PCR primers), Perkin Elmer, Rodgau-Jügesheim,
Germany ([3H]MTX, 1.48 × 1012 Bq/mmol (40 Ci/mmol),
[14C]PAH), 2.035 × 109 Bq/mmol (55 mCi/mmol), Zinsser
Analytic GmbH, Frankfurt, Germany (Quicksafe A scintil-
lation cocktail for aqueous samples) and Sigma-Aldrich
GmbH, Seelze, Germany (all other chemicals).
Animal tissue and cell cultures
Whole kidneys from fresh-killed male improved German
hybrid pigs were obtained from a local slaughter-house.
Primary porcine kidney cells (PKC) were prepared by col-
lagenase digestion from renal cortices and cultured as pre-
viously described in detail [8] with the difference that the
Percoll step employed in the original method was omitted.
Briefly, a piece of renal cortex was minced in ice-cold
modified Hank’s buffered salt solution (5.36 mM KCl,
0.44 mM KH2PO4, 145 mM NaCl, 0.34 mM Na2HPO4,
10 mM HEPES, pH 7.4, 300 mOs/kg H2O) containing
0.2 mM EGTA and 200,000 U L-1 penicillin and
200 mg L-1 streptomycin sulfate (HBSS-EGTA). After
washing in HBSS-EGTA, the tissue was digested with col-
lagenase (Type I from Clostridium histolyticum) in HBSS
(1 mg/ml) containing 4 mM CaCl2 and 1 mM MgCl2 at
37°C with gentle agitation for 20-30 minutes. Thereafter,
the cell suspension was filtered through 200 μm and
40 μm gauze and washed twice with HBSS. The final cell
pellet was resuspended in DMEM-D-Val (PAA, cat# E15-
055), to suppress fibroblast growth, supplemented with
2 mM L-glutamine, 10% FBS (FBS gold, PAA, cat# A15-
649) and antibiotics (100,000 U L-1 penicillin, 100 mg L-1
streptomycin sulfate) and seeded into Primaria™ plastic-
ware. Cultures were maintained in a standard humidified
atmosphere (95% O2, 5% CO2, 37°C). Medium was ex-
changed every second day and after one week, medium
was replaced by DMEM/F12 medium (PAA, cat# E15-
813) supplemented with 10% FBS and antibiotics. Cells
were passaged using trypsin-EDTA and cells were then
seeded onto standard cell culture plastics.
Cell viability was estimated using the Trypan Blue
exclusion assay. Only preparations of ≥90% viability were
used for culturing. Cell origin was determined by enzyme
distribution, as described earlier in detail [8-10], using
γ-glutamyl-transferase and hexokinase activity as markers
for proximal and distal tubular origin, respectively. Only
cell preparations of predominantly proximal tubular
origin (>85%) were used for culture.
LLC-PK1 and NRK-52E cells were obtained from the
European Collection of Cell Cultures, Salisbury, UK
(ECACC #86121112) and from the DSMZ, Braunschweig,
Germany (#ACC199), respectively. Cell lines were cultured
Table 2 Summary of cytotoxicity data of potential
transporter inducers (24-96 hours of exposure)







H2O 10 nM-20 μM (7) no
p-aminohippuric
acid (PAH)
H2O 10 nM-20 μM (7) no
taurocholic acid (TCA) EtOH 10 nM-20 μM (7) no
triiodothyronine (T3) PBS 100 pM-6.2 μM (7) no
dehydroepi-androsteron
sulfate (DHEAS)
H2O 10 nM-20 μM (7) no
testosterone (TEST) EtOH 10 nM-4 μM (7) no
dexamethasone (DEX) 50% EtOH 100 pM-10 μM (6) no
Data represent n = 3-4 independent experiments, conducted in duplicate.
One-way ANOVA with Dunnett’s multiple comparison test (P < 0.05).
Heussner and Dietrich BMC Cell Biology 2013, 14:55 Page 3 of 14
http://www.biomedcentral.com/1471-2121/14/55in standard plastic ware with DMEM (PAA, cat# E15-806)
containing 10% FBS and antibiotics (100,000 U L-1 penicil-
lin, 100 mg L-1 streptomycin) under standard humidified
conditions (95% O2, 5% CO2, 37°C).
Cell culture samples for RNA and protein extraction
were prepared by standard trypsin-EDTA treatment
followed by washing with PBS. Resulting cell pellets were
snap-frozen and stored at −80°C until use. Renal tissue
samples were obtained from a male Wistar rat (rKidney
cortex) and from a male German hybrid pig (pKidney
cortex), snap-frozen and stored at −80°C until use.
Growth curves
Cells were seeded in 6-well plates at a density of 5 × 103
cells cm-2 and medium was replaced every 48 hours.
Three wells were counted (technical replicates) daily from
day 1-10 (30 wells) using a Z1 particle counter (Beckman
Coulter, Krefeld, Germany) after trypsin-EDTA treatment.
Cytotoxicity experiments
Cytotoxicity experiments using the MTT reduction assay
as previously described [8], were conducted to estimate
non-toxic concentrations for subsequent analyses. All che-
micals and stock solutions (Tables 1 and 2) were sterilized
by filtration (0.2 μm) prior to testing. Briefly, after incubat-
ing the cells in the presence of MTT (250 μg mL-1) at 37°C
for 1.5 hours, the supernatant was discarded and the
intracellular formazan was solubilized with 95% (v/v)
isopropanol/ 5% (v/v) formic acid. Absorbance was read
at 550 nm using a microplate reader (Infinite M200,
Tecan, Crailsheim, Germany).
Cytotoxicity was determined in the kinetic experiments
(short substrate exposure/ high concentrations, Table 1)
after 24 hr substrate exposure, thereby ensuring that aTable 1 Summary of cytotoxicity data of transport
substrates and inhibitors (24 hours of exposure)





cimetidine (CIM) H2O 1 μM-948 μM (7) no
estrone sulfate (ES) MeOH 1 μM-1 mM (7) no
p-aminohippuric
acid (PAH)
H2O 1 μM-1 mM (7) no
methotrexate (MTX) 50% EtOH 1 μM-500 μM (6) no
probenecid (PROB) 50% EtOH 1 μM-1 mM (7) no
folic acid (FA) 0.1 M
bicarbonate
1 μM-560 μM (6) no
bromosulphophthalein
(BSP)
H2O 1 μM-500 μM (6) no
ochratoxin A (OTA) EtOH 1 μM-1 mM (7) no
ochratoxins B (OTB) EtOH 1 μM-500 μM (6) no
Data represent n = 3-4 independent experiments, conducted in duplicate.
One-way ANOVA with Dunnett’s multiple comparison test (P < 0.05).substrate exposure of up to 30 min will not encompass
substrate cytotoxicity. Conversely, in the transport induc-
tion experiments (prolonged substrate exposure/low con-
centrations, Table 2) cytotoxicity was determined after 24,
48, 72 and 96 hours of exposure. All assays were performed
with the respective vehicle controls (Tables 1 and 2) and
cadmium chloride as positive control.
Transporter induction experiments
For transporter induction experiments, freshly isolated
PKC cells were seeded (total of 2 × 104 cells cm-2) on 6-
well ThinCert PET tissue culture inserts in standard cul-
ture medium and medium was changed every 48 hours.
Cell cultures formed a tight monolayer on day 7 of cul-
ture, which was confirmed microscopically before use.
At this time point medium was changed again and incu-
bations with potential transporter inducers were started
by adding 50 nM or 1 μM of bromosulphophthalein
(BSP), p-aminohippuric acid (PAH), taurocholic acid
(TCA), triiodothyronine (T3), dehydroepiandrosteron
sulfate (DHEAS), testosterone (TEST) and dexame-
thasone (DEX) to the basolateral compartment. After
48 hours of exposure, samples for RNA extraction were
prepared by standard trypsin-EDTA treatment followed
by washing with PBS. Resulting cell pellets were snap-
frozen and stored at −80°C until use.
RNA extraction and RT-PCR analysis
Total RNA was prepared from cell pellets and minced
pieces of tissue (rat kidney and porcine kidney cortex) via
the phenol-chloroform method using Trizol (Invitrogen,
Karlsruhe, Germany). Concentration and quality was esti-
mated via 260/280 nm values. Representative samples
were tested for RNA integrity via denaturing electrophor-
esis. cDNA was prepared using 1 μg total RNA, Oligo
(dT)18 and M-MuLV reverse transcriptase according to
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2 μl cDNA sample, 2 × PCR Master Mix, specific primers
(Table 3). Amplification was performed with an initial
denaturation step at 92°C for 3 min followed by 30 cycles
of 94°C for 60 sec, 58°C for 60 sec and 72°C for 60 sec and
a final extension step at 72°C for 7 min.
PCR products were separated on 1.5% agarose gels with
1 × TAE buffer and stained with ethidium bromide. A
MultiDoc-It digital imaging system (UVP, LTF Labortech-
nik, Germany) was used for photographic documentation.
All nucleic acid analyses were performed with appropri-
ate control samples in parallel (water samples, samples
without addition of reverse transcriptase, etc.).
PCR products were sent to MWG, MWG-Biotech AG,
Ebersberg, Germany) for automated sequence analysis.
Protein preparation and analysis
Enriched membrane protein fractions were prepared
according to Scalera et al. with modifications [11]. Briefly,
cell pellets or minced tissue pieces were resuspended in
sucrose buffer (250 mM sucrose, 10 mM Tris-HCl
(pH 7.4), 1 mM EDTA, 1 mM PMSF) using a ratio of ap-
proximately 1:5 (w/v). Crude homogenates were prepared
using a motor-driven teflon potter followed by an ultra-
sound step at 4°C. Cellular debris was removed by centri-
fugation (1,000 × g, 5 min, 4°C) and the supernatants were
centrifuged again (6,000 × g, 5 min, 4°C). The pale frac-
tions of the pellets were combined with the supernatants
and centrifuged (16,000 × g, 30 min, 4°C). The resulting pel-
lets (i.e. enriched membrane fractions) were resuspended in
a minimal volume of sucrose buffer and total protein con-
tents were determined using the Bradford assay according
to manufacturer’s instructions (Biorad, Germany). Sam-
ples were diluted to a final concentration of 3 mg/ml inTable 3 Primer sequences
Name Sequence (forward) Sequence (reverse) Product
size (bp)
pGAPDH 5′-ggg cat gaa cca
tga gaa gt-3′
5′-agg cag gga tga tgt
tct gg-3′
230
pOat1 5′-tac act ggg gag
ctg tac cc-3′
5′-tct ttt cct cct gct ttc
ca-3′
246
pOat3 5′-ctt cct gtt gtc ctg
gtg gt-3′
5′-ggg aaa gac aga
ggg tca ca-3′
248
pMdr1 5′-tcc agt ttc ctt ttg
gag ga-3′
5′-tgt cct gtc gtt tgg
ttt ca-3′
176
pMrp1 5′-gca gat cac cgc ata
ctt ga-3′
5′-gtc cag gtc gtc tcg
gta ac-3′
219
pMrp2 5′-gct tgc agt tcg tct
gga gt-3′
5′-caa cag cca caa tgt
tgg tc-3′
191
pOatp1a2 5′-atg ggc cta ggg
tgt ttc tt-3′
5′-agg cat gat ggg agt
ttc ac-3′
246
Primer design was performed on the basis of sequence data available at NCBI
(http://www.ncbi.nlm.nih.gov) using Primer3 V0.2 software [47], which is online
available (http://www.primer3.sourceforge.net) with default settings.Laemmli sample buffer and incubated for 30 min at 37°C.
Proteins were separated on a 12% polyacrylamide gel
(20 μg protein/ lane) and electro-blotted onto a nitrocellu-
lose membrane. After blocking (100 mM Tris-HCl pH 7.6,
0.9% NaCl, 0.1% Tween 20, 0.1% BSA), immune-detection
was performed using rabbit anti-rat Oat1 and Oat3 (poly-
clonal, unpurified serum, Alpha Diagnostics, San Antonio,
USA) and rabbit anti-human MRP1 and MRP2 (poly-
clonal, Abcam, Cambridge, UK) in a dilution of 1:5,000
and 1:1,000, respectively, in blocking buffer overnight,
washing with TTBS (100 mM Tris-HCl pH 7.6, 0.9%
NaCl, 0.1% Tween 20), followed by incubation with the
secondary antibody (goat anti-rabbit IgG-HRP, 1:80,000)
for 1 hr at room temperature. After additional washing,
chemiluminescent detection was performed using ECL
Plus and Hyperfilm ECL (GE Healthcare, Germany).
The detection of pOAT1 and pOAT3 by specific anti-
bodies was confirmed using the respective control
blocking peptides (16 aa peptide of rat OAT 1 or OAT3
that was used as part of the antigen for antibody pro-
duction) according to manufacturer’s instructions
(Alpha Diagnostics, San Antonio, USA).
Transport assays (kinetics)
For transport studies, PKC were seeded (1 × 105 cells/cm2)
on 6-well PET filter inserts with 0.4 μm pore size. The use
of filter inserts allows measurement of transport across
the BLM (basolateral membrane) and the BBM (brushbor-
der membrane) by addition of substrates to media in the
lower and upper compartment, respectively. After seven
days of standard culture conditions a tight cell monolayer
was present and culture medium was replaced with assay
medium (without FBS), containing the appropriate con-
centration of substrate and 925 Bq (=25 nCi) of radiola-
belled substrate. The cells were incubated at 37°C for the
indicated times. After incubation, the media from the
upper and lower chamber were saved and the filter inserts
were washed carefully three times with ice-cold PBS
(136.9 mM NaCl, 2.7 mM KCl, 8.1 mM Na2HPO4,
1.5 mM KH2PO4, pH 7.4) and cells were solubilized with
0.5 M NaOH for at least one hour at RT. Thereafter, cells
were acidified with 1 M HCl and an aliquot was used for
protein determination using the Bradford assay. 1 ml of
medium from each compartment and of solubilized cells
was placed into 10 ml scintillation cocktail and radio-
activity was measured in a Beckman LS 6500 scintil-
lation counter. In addition, several controls were employed
(medium, solubilization solution, solubilized cells, total
radioactivity (925 Bq) and total radioactivity (925 Bq) in the
medium) to determine blanks, color quenching and hand-
ling variability.
Transport time courses were determined using a mix-
ture of 50 μM substrate and 925 Bq radiolabelled substrate
and 0, 1, 5, 10 and 30 min time points. As preliminary
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uptake could be obtained after 60 and 120 min incuba-
tion, these longer substrate exposure time points were
omitted from further experimentation.
Transport concentration dependency was determined
using nominally 0, 1, 5, 10, 20, 50 and 100 μM substrate,
supplemented with radiolabelled substrate (925 Bq) and
30 min of incubation. The solutions used were measured
in parallel to the experiment in order to determine the real
concentrations applied resulting in 0.2, 1.1, 4.8, 9.5, 18.7,
46.3 and 92.2 μM. Inhibition studies were performed using
a mixture of 50 μM substrate, 925 Bq radiolabelled sub-
strate and inhibitors (1 mM) and 10 min incubation time.
For transport studies, tightness of the cellular mono-
layers was inspected microscopically before use. Addition-
ally, radiolabelled substrates were measured in the both
chambers (above and below the cell layer) to determine
cell layer leakiness. In case of lacking or reduced tightness
of the monolayer, very high counts (dpm) were measured
in the respective opposite compartment. These resulting
counts (dpm) were several-magnitudes greater than those
that could have been expected from potential transepithe-
lial transport. Data from cell preparations with such ap-
parent cell layer leakiness were omitted from calculation.
Data analysis
All numerical calculations and graphical representations
were performed using MS Excel 2007 and GraphPad
Prism 4.03. Data from growth curves were calculated as
means ± SD from three technical replicates. Cell number
doubling times were estimated from the logarithmic
phase of the growth curve.
Cytotoxicity data were calculated as means ± SEM
from at least three independent replicate experiments
conducted in technical duplicates, followed by a One-
way ANOVA with a subsequent Dunnett’s multiple com-
parison test (P < 0.05). For the positive control (CdCl2), a
non-linear regression (5-PL, 95% CI) analysis was per-
formed and effective concentrations (EC50) determined.
For kinetic data, raw transport data (dpm) were submit-
ted to intra-assay normalization using the blanks de-
scribed above and calculated using the following equation:
mean dpm total volume
counted volume 60 sec specific activity  protein content assay time
¼ substrate pmol=mgminð Þ
Non-linear regression (5-PL, 95% CI) analysis was per-
formed on data of 3-4 independent replicate experi-
ments conducted in technical duplicates providing for a
Km and R
2.
Densitometry was performed on agarose gels using
Biorad QuantityOne V4.6.1. Each value was normalized
with the respective GAPDH value. To reduce residual back-
ground noise from differing absolute values of independentreplicate experiments, all experiments were run with the
same positive control (RNA sample extracted from
porcine kidney cortex), which were also used for intra-
experimental normalization. Data were presented as mean
transporter expression/ housekeeping gene expression vs.
positive control/ housekeeping gene expression ± SEM
from at least three independent replicate experiments.
Results
Basic characterization of PKC
PKC cultures formed monolayers with the typical epithe-
lial appearance and domes (Figure 1). Additionally, a
basolateral-apical polarity can be assumed at confluence
on the basis of the transport experiments, as described
below (Figures 2 and 3). PKC growth patterns were inves-
tigated several times in freshly isolated cell cultures as well
as for subsequent cell passages. PKC showed a typical
growth curve with a lag-phase of up to 50 hours, a max-
imum final cell density of almost 1 × 105 cells cm-2 at con-
fluence and a cellular doubling time of approximately
29 hours. No differences in cell number and cellular doub-
ling time were usually observed between cell passage zero
and three (Figure 4), however signs of degeneration or,
more likely, senescence in individual cells (enlarged cell
bodies with cytoskeletal changes (Figure 5D)) were appa-
rent especially within cell layers of the otherwise normally
looking passage three cell layer (Figure 5C).
Expression of selected transporters at mRNA and
protein level
Gene expression analysis of transporter mRNA in PKC in-
cluded pMdr1, pMrp1, pMrp2, pOatp1a2, pOat1 and
pOat3. Porcine GAPDH (pGAPDH) was used as house-
keeping gene and total RNA from porcine renal tissue
(pKidney) and deionized water (dH2O) served as positive
and negative controls, respectively. No signal could be ob-
tained for pMdr1 and pOatp1a2 neither in the cells nor in
the organ tissue preparations (data not shown). All other
transporter mRNA was detectable in the tissue and cell
samples (Figure 6) and the results were confirmed via
sequencing of the respective RT-PCR products with 100%
identity in each case. LLC-PK1 and NRK-52E cell lines
were negative for all transporters tested (data not shown).
Protein analyses using SDS-PAGE followed by Western
blotting and immunodetection with specific antibodies
were performed only for transporters that were positively
detected on mRNA level. For this purpose, enriched mem-
brane fractions isolated from confluent PKC, NRK-52E
and LLC-PK1 cultures and from porcine and rat renal
cortex tissue were used. These experiments confirmed the
mRNA expression data for pOat1 and pOat3 in PKC,
although the protein bands were different from those ob-
tained with the renal tissue samples from rat and porcine
origin (Figure 7). The blots show immunoreactive proteins
Figure 1 Representative pictures of primary porcine kidney
epithelial cells (PKC) at different states of confluence. Pictures
show PKC cultures of passage 0, 7 days after isolation with different
confluence levels: A, post-confluent (>100% confluence); B, confluent
(100% confluence); C, semi-confluent (~70% confluence); the used
terms of confluence define the various density states of the cultures,
i.e. non-confluent (described as <100% confluence), confluent (a state
where the dish is completely covered with cells, described as 100%
confluence) and post-confluent (a state, where the maximal cell
number is reached, described as >100%). The latter does not mean that
these cells grow in multilayers, but that they are able to close ranks
more tightly before they stop proliferating due to contact inhibition.
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the antigen-antibody reaction was demonstrated by pre-
liminary experiments using the respective control peptides
(Alpha Diagnostics) according to manufacturer’s instruc-
tions. Similar but less pronounced results were obtained
for pOat3, whereas no signals were detected for Mrps in
porcine tissue and cells (data not shown).
Expression of selected transporter mRNAs with respect to
time and cell density
Cells from the same batch of freshly isolated cells (passage
0) were seeded at different cell densities resulting in two
different experimental designs. At first, pOat1 and pOat3
expression was tested at various levels of confluence after
7 days in culture. Expression levels decreased for both
transporters with decreasing cell density (Figure 8A-B).
Then, transporter expression was investigated at the same
level of confluence (i.e. at post-confluence) in PKC after
different times in culture. Expression levels for both trans-
porters decreased with culturing time (Figure 8C-D).
Expression of selected transporter on mRNA and protein
level in PKC cultures
Porcine Oat1/3 expression was examined over several
passages of PKC in culture. At the transcription level,
the expression of both transporters decreased in freshly
isolated cells (passage 0) during culturing and was ab-
sent after passaging and re-culturing of the cells (passage
1 ff.; Table 4). In enriched fractions isolated from conflu-
ent PKC cultures (passage 0-3) and from porcine renal
cortex tissue pOat1 protein was detectable via Western
Blotting analysis (Figure 7) and no change in expression
was observed (Table 5). Compared to pOAT1, a lower
protein signal was observed for pOat3 in freshly isolated
cells and in cultures of passage 0 and 1. Thereafter,
pOat3 protein was no longer detectable (Table 5). No
specific mRNA or protein was detectable in LLC-PK1
and NRK-52E cells.
Transporter induction
To ensure that no cytotoxic side effects could influence the
transporter induction experiments, basic cytotoxicity was
tested using the MTT reduction assay, which is for many
substances one of the most sensitive endpoints for porcine
renal cells [8]. The sensitivity of the cells was tested using
cadmium chloride as a positive control in a final concentra-
tion range of 1-500 μM resulting in a typical sigmoid
concentration-response curve (Figure 9). Moreover a time-
dependent effect was observed with an EC50 of 102.8 μM
(95% CI 80.7-131.0 μM, R2 = 0.82) and 57.2 μM (95% CI
53.7-60.9 μM, R2 = 0.97) for 24 and 48 hours of exposure,
respectively. Exposure >48 hours did not result in further
increased cytotoxicity (data not shown). The potential
transporter inducers (Table 2) did not show any cytotoxic
























































Figure 2 Cellular PAH uptake. A, uptake vs. PAH concentration; B, uptake vs. time; data represent means from 3-4 independent experiments
performed in duplicates ± SEM.
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unlikely that they would cause cytotoxicity within the time
frame of the induction experiments.
Preliminary experimentation included a comparison of
the standard medium (DMEM/F12, with 10% FBS and
antibiotics) and a serum-free DMEM/F12, supplemented
with transferrin, insulin, hydrocortisone, EGF, triiodothyr-
onine, epinephrine (SingleQuot, Cambrex Bio Science,
Verviers, Belgium) and 50 μg/L PGE1 (Acros Organics,
Geel, Belgium), 5 μg/L selenious acid and antibiotics. No
differences in transporter expression were observed (data
not shown).
No expression of either Oat1 or Oat3 could be in-
duced at all conditions applied and tested via RT-PCR.
Kinetics and function of organic anion transport in PKC
Preliminary cytotoxicity testing using the MTT reduction
assay as described above confirmed that the chosen sub-
stances (transporter substrates and inhibitors) and resp-
ective concentrations are non-toxic within 24 hours of
exposure (Table 1). Therefore it can be assumed that these
substances are unlikely to cause cytotoxicity in the time
frame of up to two hours within the transport experiments.[14C]PAH and [3H]MTX were chosen as model trans-
port substrates for experimentation. Whereas [3H]MTX
uptake was negligible, [14C]PAH uptake occurred across
the basolateral (BLM) and across the brushborder mem-
brane (BBM). Kinetics of BLM uptake of PAH in conflu-
ent PKC was measured as a model substrate for pOat1
and pOat3. Uptake showed saturation kinetics (Figure 2A)
and non-linear regression analysis yielded a reasonably
good fit (R2 = 0.85). Similarly, PAH uptake across the
BBM, for which the carrier(s) has (have) not been identi-
fied, was also characterized by saturable uptake with good
fit (R2 = 0.92) (Figure 2A).
BBM and BLM uptake was found to be different in
capacity and affinity, with BBM uptake being about 3
times higher compared to BLM uptake (Figure 2A). This
is also reflected by the Km values of 58.8 ± 12.6 μM and
187.2 ± 70.2 μM (mean ± SEM, n = 3) for uptake across
BBM and BLM, respectively. PAH uptake was time-
dependent with saturation reached within approximately
5-10 minutes (Figure 2B).
To provide additional validation of the transporter
function in PKC, inhibition of PAH and uptake was




























































Figure 3 Inhibition of cellular PAH uptake. A, BBM (brushborder
membrane) uptake; B, BLM (basolateral membrane) uptake; columns
represent means from 3-4 independent experiments performed
in duplicates ± SEM.
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http://www.biomedcentral.com/1471-2121/14/55PAH BBM uptake by up to 30% (Figure 3A), whereas
CIM, FA and OTB showed similar inhibitory effects on
the PAH BLM uptake (Figure 3B). All other substances
tested (Table 1) were not able to inhibit PAH uptake























Figure 4 Representative growth curves of PKC of passage 0-3.
Data represent means ± SD from 3 technical replicates.Discussion
A good in vitro model should approximate an in vivo-like
behavior as closely as possible in order to reflect most
likely the in vivo situation [12]. Regarding renal physiology
of different species, humans are more closely related to
pigs than to rodents [5,13]. Therefore porcine renal cells
could prove to be a valuable tool for renal in vitro toxicol-
ogy. Such a renal in vitro model should display specific
characteristics (e.g. structural organization) and func-
tions (e.g. transepithelial transport) of the respective
part of the kidney. This study thus aimed to provide
data in order to enable an informed assessment of the
suitability of primary porcine renal cells as a model for
in vitro toxicological testing.
The kidney plays an important role in the elimination of
harmful compounds from the body and the reabsorption
of vital substances from the glomerular filtrate back into
the body. Both types of compounds need to be transported
across the membranes of the tubular cells which is real-
ized by specifically localized transporters especially those
of the ABC and SLC families [14-25]. A good in vitro kid-
ney model must therefore functionally express these trans-
porters in the correct location. In the present study, PKCs
were characterized with respect to morphological features
(monolayer with the typical epithelial appearance and
dome formation). A basolateral-apical polarity can be as-
sumed due to the transporting capabilities observed (see
below). This is in accordance with the data from other
researchers who additionally tested similarly prepared and
cultured PKCs for membrane-specific localization of
pMdr1 (abcb1, apical) and pNbc1 (slc4a4, basolateral)
using confocal microscopy [26]. These data corroborate
earlier findings in PKC, including stable cytokeratin ex-
pression patterns up to passage 2 and correspondingly
very low but stable vimentin expression as markers of
epithelial and mesenchymal cell types, respectively [8,27].
Growth patterns (cellular doubling time, total cell number,
monolayer formation) of PKC were found to be similar
over three passages although signs of senescence (and/or
degeneration) were increasing with time in culture and
were apparent especially for cells of passage three. En-
larged cell bodies and cytoskeletal changes are typical phe-
nomena known for senescent cells. Cellular degeneration,
especially with respect to change of phenotype to a more
fibroblastoid type would possibly be reversible and would
include for example a change in marker protein expres-
sion. The latter was not observed with cytokeratin and
vimentin in earlier studies [8,27].
The data presented here demonstrate that PKC express
various transporters at the mRNA level including pMrp1
(abcc1), pMrp2 (abcc2), pOat1 (slc22a6) and pOat3
(slc22a8), whereas pMdr1 (abcb1) and pOatp1a2 (slco1a2)
mRNA could not be detected in either the PKCs or in
the porcine cortical tissue. The latter might suggest the
Figure 5 Pictures of PKC at different passages. Pictures show confluent PKC cultures of passage 0 (A-B) and 3 (C-D).
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http://www.biomedcentral.com/1471-2121/14/55absence or very low abundance of these transporters in
porcine kidney and PKC, a result of the detection tech-
nique employed, or a combination of both, i.e. low
abundance and limited detection. Results published by
Schlatter et al. confirm the latter interpretation as they
demonstrated pOatp1a2 mRNA in their PKC, but only
in freshly isolated cells and with a very faint band after a
very high number of PCR cycles [26]. Moreover, theyFigure 6 Results of mRNA analysis (Representative picture). 1.5% TAE-
inverted); pKidney: RNA from porcine renal cortex; PKC, porcine kidney cell
dehydrogenase; pMrp1/2, porcine multidrug resistance-associated protein 1were able to detect pMdr1 mRNA in cultures from
different cell preparations using quantitative PCR [26].
To confirm the presence of various transporters in
PKC detected at the mRNA level Oat protein expression
was assessed also via Western blotting analysis. Due to
the fact that transporters are low abundant proteins rela-
tive to total cellular protein [28], it was necessary to use





agarose gels with ethidium bromide UV-detection (picture colors are
s; dH2O, deionized water; pGAPDH: porcine glyceraldehyde phosphate
and 2; pOat1/3, porcine organic anion transporters 1 and 3.
Figure 7 Results of Oat1 protein analysis (Representative
picture). PKC, porcine kidney cells; rKidney, tissue from rat kidney;
pKidney, tissue from porcine kidney; P0-3, passage number.
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http://www.biomedcentral.com/1471-2121/14/55high backgrounds. These experiments however confirmed
the mRNA expression data for pOat1 and pOat3 in PKC,
although the protein bands were different from those ob-
tained with the renal tissue samples from rat and porcine
origin. Specific immunoreactive proteins at approximately
75, 45 and 40 kDa were detected. It is suggested, that the
large protein (~75 kDa) represents the mature, fullyPKC, P0,
7d post preparation
pKidney













d7 d8 d9 d10 d11
Figure 8 Effect of level of confluence and culturing time of PKC on p
agarose gels of analyzed samples from cell cultures with varying cell densit
results from cell cultures with varying cell density (B) or with varying times
value and are expressed as means with SEM from 3-4 (B) or 4 (D) indepen
renal cortex); level of confluence: 100% represent confluent cultures, valuesglycosylated form. The smaller proteins, which predomin-
ate in vitro, may be deglycosylated forms of splice variants
[29] and/or forms that are more affected by the experi-
mental procedure, as previously been reported for human
OAT1 [30]. However despite that Schlatter et al. [26]
demonstrated the expression of pMdr1 (abcb1), pMrp1
(abcc1) and pMrp2 (abcc2) in PKC by immunocytochem-
istry using human protein derived antibodies, Mrp pro-
teins were not detectable in porcine cortical tissue and
cells in the experimental set-up reported here. The latter
lack of detection, which stands in contrast to the mRNA
data, most likely is due to the use of the Mrp antibodies
employed. Here, polyclonal anti-human MRP1/2 anti-
bodies were used, that had been predicted to cross-react
with the porcine homologues. Obviously this was not the
case as these transporters were not detectable in PKC as
well as in porcine cortical tissue, although the general
function of the antibodies was confirmed by earlier ex-




Oat mRNA expression. Color-inverted pictures from representative
y (A) or with varying times in culture (C); summarized densitometric
in culture (D); data were normalized with the respective pGAPDH
dent experimentations vs. positive control (pKidney, RNA from porcine
larger than 100% represent postconfluent culture states.
Figure 9 Cytotoxicity of cadmium chloride in PKC. Nonlinear fit
(5-PL) of normalized and transformed means from 3-4 independent
experiments performed in duplicates ± SEM.
Table 4 Summarized results of pOat mRNA analysis
Samples N pOat1 pOat3 GAPDH
Porcine kidney (male) 2 + + +
PKCm, P0, freshly prepared 4 + + +
PKCm, P0, 9-10d 4 +/- +/- +
PKCm, P1, 18-24d 4 - - +
LLC-PK1 4 - - +
NRK-52E 4 - - +
N, Number of independent samples analyzed; P, Passage number of cell
cultures; d, Total time of culture in days; +, Positive detection, +/- Ambiguous
results; -, No detection.
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http://www.biomedcentral.com/1471-2121/14/55negative results stand also in contrast to data from other
investigators showing that Mrps are highly expressed in
the kidney of several other species, as reviewed by Klaassen
and Aleksunes [24].
In contrast to PKC, the continuous cell lines LLC-PK1
and NRK-52E were negative for all transporters tested at
mRNA and protein level. Whereas other investigators de-
scribed low but detectable functional expression of these
transporters in NRK-52E cells [31-34], LLC-PK1 cells were
extensively used as models for transporter over-expression
by transfection due to their lack of endogenous transporter
expression [35-41]. The negative results for NRK-52E cells
here are most likely a result of using different strains of
NRK-52E cells (ATCC vs. DSMZ), but different cell culture
or detection conditions might be causative as well.
Transporter functionality was assessed using radiola-
belled PAH and MTX as model transport substrates. PAH
uptake occurred across the BLM and BBM, but was found
to be different in capacity and affinity, with BBM uptake
being about 3 times higher compared to BLM uptake.
PAH uptake was time-dependent with saturation reached
within approximately 5-10 minutes. MTX, OTA and BSP
reduced the PAH BBM uptake by up to 30%, whereas
CIM, FA and OTB showed similar inhibitory effects on
the basolateral PAH uptake. All other substances testedTable 5 Summary of pOat protein analysis
Samples N pOat1 pOat3
rKidney Cortex 4 +++ ++
pKidney Cortex 4 ++ ++
PKC P0, freshly isolated 4 + +/-
P0, postconfluent 4 ++ +
P1, postconfluent 4 ++ +
P2, postconfluent 4 ++ -
P3, postconfluent 4 ++ -
LLC-PK1 postconfluent 4 - -
NRK-52E postconfluent 4 - -
N, Number of independent samples analyzed; P, Passage number of cell cultures;
+, Positive detection of different intensity, +/- Ambiguous results; -, No detection.did not inhibit PAH uptake from either the basolateral or
luminal direction.
The observed PAH transport kinetics in PKCs as deter-
mined appeared typical for the expected specific transport
and thus was considered, at least in part, as attributable to
specific expression of pOat1 and pOat3. However, due to
the lack of corresponding published data for porcine cells
the latter findings could not be corroborated. Indeed,
Schlatter and co-workers who also investigated transport
in PKC did not report Km values or other parameters that
might be suitable for comparison [26]. On the one hand,
the calculated Km values for PAH uptake across BBM and
BLM were comparable to those observed in primary
human proximal tubular cells (BLM Km of 57.5 ± 4.1 μM;
BBM Km = 36.6 ± 1.2 μM [28], which is consistent with the
high protein homology between porcine and human OATs.
The amino acid sequence of pOat1 and pOat3 showed
89% and 81% homology to the human counterparts, re-
spectively [29,42]. Hagos and co-workers investigated two
slice variants of pOat1 and one variant of pOat3 expressed
in Xenopus laevis oocytes [29,42]. While one pOat1 variant
did not show any affinity for [3H]PAH, the other presented
with an apparent Km for [
3H]PAH of 3.75 ± 1.6 μM. The
latter uptake could be inhibited by 0.5 mM glutarate or
1 mM probenecid [25,29], which is comparable to that ob-
served with hOAT1 (Km = 3.9-22 μM) [25]. The reported
Km values refer to single transporter proteins overex-
pressed in oocytes, whereas the presented Km values in
our study cannot be assigned to a single transporter but ra-
ther to mixed action of at least two different pOats. Never-
theless, based on expression data the observed uptake of
PAH is most likely related to pOat1 and to a lesser extent
to pOat3. ES, a model substrate for pOat3, was not able to
inhibit PAH uptake in our study, which further suggests
a predominantly pOat1-mediated uptake. Functional
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http://www.biomedcentral.com/1471-2121/14/55investigations of pOat3 expressed in X. laevis oocytes re-
sulted in a high affinity [3H]ES transport with an apparent
Km of 7.8 ± 1.3 μM with an inhibitory effect of glutarate,
DHEAS and probenecid [42], which is similar to hOAT3
(Km = 3.1-9.5 μM) [25]. In our study, probenecid did not
show any inhibitory effect on PAH uptake from either the
basolateral or the luminal side suggesting that either an
additional transporter may be involved in PAH uptake
which is not sensitive to probenecid or that the detected
transporters pOat1 and pOat3 are indeed slightly different
(glycolysation-) variants when compared to their in vivo
counterparts.
MTX has been shown to interact with several human
transporters including hOAT1 (Km = 554-724 μM),
hOAT3 (Km = 10.9-21.1 μM), hOAT4 (Km = 17.8 μM),
hMRP2 (Km = 250-480; 2,500-3,000 μM) and hMRP4
(Km = 220-1,300 μM) [43]. Cellular MTX uptake was
shown to be mediated by hOAT1/3, whereas hOAT4
and hMRPs seem to be involved in MTX efflux [43]. In
human kidney cells (HKC), comparable to the PKC cells
employed here, hOAT1-associated MTX transport was
reported across the BLM with Km = 28.5 ± 1.1 and across
the BBM with Km = 80.4 ± 3.4 μM [28]. Based on human
data, it can be assumed that MTX uptake is of high affin-
ity/ low capacity, whereas the opposite seems to be true
for MTX efflux. If the same holds true for the renal
porcine transporters tested here, the results obtained with
PKC could be explained by a highly efficient MTX excre-
tion surmounting the concurrent uptake and thus result-
ing in the low intracellular concentrations determined.
Indeed, MTX has been used by others in PKC as a model
substrate for Mrp1-6 (abcc1-6), and hypothesized to
pump MTX out of the cells [26]. Beyond the latter, MTX
may also not be a substrate or a low affinity/low capacity
substrate for the transporter variants expressed in PKC.
Due to the low intracellular concentrations determined,
the question may also be raised whether the transporter
variants expressed are truly functional.
mRNA expression levels of pOat 1 and pOat3 in PKCs of
passage 0 at different states (cell density and time in culture)
was examined and showed that the expression levels for
both transporters decreased over time. PKCs of passage 1
did not show any mRNA expression of pOat1 and pOat3 at
all. This confirms earlier results from Schlatter and co-
workers who observed a down-regulation of pOat1 in cul-
ture and detected pOat3 in freshly isolated cells only [26].
The latter observations were also true for other transporters
such as pOct1 (slc22a1), which was detectable in freshly iso-
lated cells only, pMrp1 (abcc1) was up-regulated and pMrp2
(abcc2) mRNA expression was down-regulated in culture
[26]. To provide a more comprehensive picture of the situ-
ation, pOat1/3 expression in PKC was also investigated at
the protein level. In contrast to the mRNA data, pOat1
was detectable in PKC up to passage three, whereas pOat3was present only up to passage one and then at a much
lower amount than pOat1. The latter observations suggest
that in PKC protein stabilization and/or degradation
mechanisms could be altered. This effect and the observed
alterations in mRNA expression further confirm the as-
sumption of increasing senescence in the PKC cell strain.
Differences in transporter function amongst individ-
uals may be the result of an up-or down-regulation of
OAT expression subsequent to prior exposure to drugs
and xenobiotics, or to differences in hormonal status [25].
In addition to the initial expression, post-translational
mechanisms including glycosylation, phosphorylation,
ubiquitination and SUMOylation seem to be involved in
regulating the level and functionality of the expressed
transporters [24,25]. While glycosylation appears to be
critical in membrane targeting/ trafficking, protein fold-
ing and possibly regulation of OAT function, data suggest
that phosphorylation and interactions of the OATs with
protein partners may change OAT function [24,25]. Indeed
T3, DHEAS, TEST and DEX were proposed by several
authors [26,44,45] as potential inducers of transporter ex-
pression. Accordingly PKC were treated with T3, DHEAS,
TEST, BSP, PAH, TCA and DEX and tested whether this
would result in a more stable expression of transporters.
However, none of the tested substances showed any stimu-
latory effect on transporter mRNA expression in the tested
concentration and time frame. Whether this is due to spe-
cies differences or to the lacking tissue structure compared
to renal slices or tubules used in other studies [44-46]
remains to be elucidated.Conclusions
A porcine renal in vitro model would be cheap, easy to
establish, to handle and readily available. The PKC tested
here were characterized comprehensively with respect to
general features and transport functions. On the basis of
the results obtained and the comparison of parts of the
data with previously published information, it can be con-
cluded that primary PKC, but not necessarily the resulting
PKC cell strain, could represent a valuable model for
in vitro toxicology that possibly could be used as an alter-
native to human primary cells, provided a more in-depth
characterization of transport and xenobiotic metabolism
and toxicity is carried out. Furthermore and pending more
in-depth understanding of the expression and functional-
ity of transporters, primary PKC can be used to study toxi-
cokinetics and toxicodynamics of substances as well as
tubular toxicity requiring specific transport mechanisms.Additional files
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